SLIT2 and central nervous system cancer: This is consistent with our previous studies of lung cancer16 and breast cancer15 and with other studies such as medulloblastoma43 and glioma.44 Moreover, we found that Slit2 inhibits the EMT process, which may support for the clinical application of Slit‐Robo signalling.